JGC
AMGN icon

J. Goldman & Co’s Amgen AMGN Stock Holding History

J. Goldman & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,900
Closed -$3.48M – 702
2026
Q1 		$3.48M Sell
9,900
-33,588
-77% -$12M 0.1% 236
2025
Q4 		$14.2M Sell
43,488
-29,314
-40% -$9.3M 0.37% 72
2025
Q3 		$20.5M Buy
+72,802
New +$21.1M 0.52% 51
2024
Q4 		– Sell
-53,446
Closed -$17.2M – 449
2024
Q3 		$17.2M Sell
53,446
-3,428
-6% -$1.12M 0.48% 55
2024
Q2 		$17.8M Buy
56,874
+16,465
+41% +$4.84M 0.5% 60
2024
Q1 		$11.5M Sell
40,409
-10,325
-20% -$3.02M 0.37% 89
2023
Q4 		$14.6M Sell
50,734
-52,803
-51% -$14.4M 0.59% 56
2023
Q3 		$27.8M Buy
+103,537
New +$25.8M 0.97% 27
2022
Q4 		– Sell
-28,681
Closed -$6.46M – 368
2022
Q3 		$6.46M Buy
28,681
+7,909
+38% +$1.92M 0.31% 96
2022
Q2 		$5.05M Buy
+20,772
New +$5.09M 0.25% 104

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

J. Goldman & Co's AMGN Position: Q2 2026 in Review

J. Goldman & Co sold out of Amgen (AMGN) in Q2 2026, closing a stake of 9,900 shares — an estimated $3.48M sold.

J. Goldman & Co first reported a position in AMGN in Q2 2022 and held it in 10 quarters. The position peaked at $27.8M in Q3 2023. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • J. Goldman & Co reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • J. Goldman & Co sold 9,900 Amgen shares in Q2 2026, an estimated $3.48M.
  • J. Goldman & Co first reported a position in Amgen in Q2 2022 and held it in 10 quarters.
  • J. Goldman & Co's Amgen position peaked at $27.8M in Q3 2023.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.